All companies
Visit website
AiViva
OperatingAiViva Holding Limited
Healthcare · Biotech · Founded 2020
Developing treatments that change lives
Post-money valuation ⓘ
$49.8M
As of Dec 2022 · from AiViva Common Stock 1 · pre-money + amount raised, not a traded price
Total raised
$728,010
Across 1 round since 2022
Latest share price
$2.00
AiViva Common Stock 1 offering price
Financials
FY2020–FY2024 · from SEC filings · hover any figure for its source$153K
−$4.5M
2020
$17K
−$4.0M
2021
$0
−$4.3M
2022
$17K
−$4.0M
2023
$0
−$4.3M
2024
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2020
FY2021
FY2022
FY2023
FY2024
Income statement
Revenue
$153,000
$17,000
$0
$17,000
$0
Cost of goods sold
$0
$0
$0
$0
$0
Gross margin
100%
100%
—
100%
—
Net income
-$4,542,477
-$3,960,872
-$4,262,969
-$3,960,872
-$4,262,969
Taxes paid
$800
$4,070
$5,867
$4,070
$5,867
Balance sheet
Cash
$5,419,620
$3,601,734
$4,452,621
$3,601,734
$4,452,621
Accounts receivable
$0
$0
$0
$0
$0
Total assets
$8,589,570
$4,583,591
$10,904,754
$4,583,591
$10,906,012
Short-term debt
$597,651
$0
$0
$0
$0
Long-term debt
$0
$0
$0
$0
$0
Total liabilities
$597,651
$0
$0
$0
$0
Other
Headcount
—
9
8
9
8
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$49.8M
post-money
AiViva Common Stock 1
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $728K / $5MInvestors 423Post-money $49.8M
Reg CF annual-report compliance
Not requiredFiled Form C-TR (terminated reporting)
Filed 3 of 4 annual reports (FY2022–FY2025)
423 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
View all 12 filings on EDGARSource: ManualCIK 0001928381Share price $2.00
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.